Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Trial of VLTS-589 in Subjects With Intermittent Claudication

ClinicalTrials.gov ID: NCT00068133

Public ClinicalTrials.gov record NCT00068133. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 31, 2026, 9:53 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Multicenter, Double-Blind, Placebo-Controlled, Trial of VLTS-589 in Subjects With Intermittent Claudication Secondary to Peripheral Arterial Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the safety and tolerability of VLTS-589 compared with placebo, administered bilaterally to the lower extremities, in subjects with intermittent claudication and to determine the effect of VLTS-589 in peak walking time (PWT) for subjects receiving VLTS-589 compared with subjects receiving placebo.

Study identification

NCT ID
NCT00068133
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Valentis
Industry
Enrollment
100 participants

Conditions and interventions

Eligibility (public fields only)

Age range
40 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2003 (Type not available)
Primary completion
Not listed
Completion
Jun 2005 (Type not available)
Last update posted
Jun 24, 2005

2003 – 2005

United States locations

U.S. sites
20
U.S. states
18
U.S. cities
20
Facility City State ZIP Site status
Cardiology Pc Birmingham Alabama 35211 —
Arizona Heart Institute Phoenix Arizona 85016 —
Access Clinical Trials-Cardiovascular Research Beverly Hills California 90210 —
Jacksonville Heart Center Jacksonville Florida 32207 —
Heart Specialists of Sarasota Clinical Research Center Sarasota Florida 34239 —
American Cardiovascular Research Institute Atlanta Georgia 30342 —
Rush Presbyterian St. Luke's Medical Center Chicago Illinois 60612 —
Prairie Heart Institution at St. John's Hospital Springfield Illinois 62701 —
The Care Group Indianapolis Indiana 46260 —
New Orleans Center for Clinical Research New Orleans Louisiana 70119 —
Androscoggin Cardiology Associates Auburn Maine 04210 —
University of Michigan Health Systems Ann Arbor Michigan 48109 —
Minneapolis Heart Institution Foundation Minneapolis Minnesota 55407 —
Dartmouth-Hitchcock Medical Center Lebanon New Hampshire 03756 —
St. Vincent's Hospital New York New York 10011 —
Duke Clinical Research Institute Durham North Carolina 27715 —
University of Oklahoma Health Science Center Oklahoma City Oklahoma 73104 —
Vanderbilt University Medical Center Nashville Tennessee 37232 —
The Methodist Hospital Houston Texas 77030 —
Daniel Gottleib, MD Seattle Washington 98166 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00068133, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 24, 2005 · Synced Oct 31, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00068133 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →